Acute Pulmonary Embolism Clinical Trial
Official title:
Dynamic Changes of Circulatory and Respiratory Function After Thrombolysis in Patients With Acute Pulmonary Embolism
The investigators expect to enroll about 80-100 acute pulmonary embolism patients treated with thrombolysis in two hospitals. Dynamic changes of cardiopulmonary function after thrombolysis are detected to evaluate which indicators can quickly reflect the effectiveness of thrombolysis.
About 50 acute pulmonary embolism(APE) patients treated with thrombolysis are enrolled in the First Affiliated Hospital with Nanjing Medical University and Nanjing Drum Town Hospital from January 1, 2020, to December 31, 2021. According to the 2019 ESC guideline, the standards for thrombolysis in APE patients are as follows: within 2 weeks of onset; high-risk pulmonary embolism; medium-high-risk pulmonary embolism with symptoms of aggravation. Investigators dynamically monitor cardiopulmonary function of participants after thrombolysis, including blood pressure, heart rate, respiratory rate, blood gas analysis, 2-dimensional echocardiography (left and right ventricular diameter, pulmonary artery pressure, interventricular septum) and laboratory tests (cTnT,pro-BNP).participants are divided into two groups: thrombolytic success group and thrombolytic failure group according the previously reported criterion which is evaluated 48h after thrombolysis. Cardiopulmonary characteristics are analyzed to seek accurate and rapid index to reflect success of thrombolysis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00519506 -
A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli
|
Phase 2 | |
| Not yet recruiting |
NCT04110275 -
Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA)
|
Phase 2 | |
| Completed |
NCT05318092 -
Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
|
N/A | |
| Not yet recruiting |
NCT06189313 -
CLEANer Aspiration for Pulmonary Embolism
|
N/A | |
| Not yet recruiting |
NCT05792397 -
TwiFlow Thrombectomy Catheter sYstem for Acute Pulmonary Embolism (Twi-TYPE Study)
|
N/A | |
| Completed |
NCT01604538 -
Italian Pulmonary Embolism Registry - IPER
|
N/A | |
| Completed |
NCT03631810 -
Contemporary Clinical Management Of Acute Pulmonary Embolism
|
||
| Recruiting |
NCT03504007 -
Registry of Patients Prescribed Anticoagulation
|
||
| Completed |
NCT01513759 -
Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
|
Phase 3 | |
| Completed |
NCT03108833 -
A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism
|
Phase 2 | |
| Completed |
NCT04037423 -
European Database on Catheter-directed Treatment of Pulmonary Embolism.
|
||
| Not yet recruiting |
NCT05469724 -
Clinical Pulmonary Embolism
|
||
| Completed |
NCT01014156 -
Epoprostenol in Pulmonary Embolism
|
Phase 4 | |
| Recruiting |
NCT06038630 -
129Xe MRI Cardiopulmonary
|
Phase 2 | |
| Recruiting |
NCT06192199 -
The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism
|
||
| Completed |
NCT03966079 -
Thrombolysis Endovascular Treatment of Pulmonary Embolism
|
Phase 3 | |
| Recruiting |
NCT03916302 -
Pulmonary Embolism WArsaw REgistry
|
||
| Recruiting |
NCT06062329 -
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
|
N/A | |
| Not yet recruiting |
NCT04480892 -
Fibrinolytic Deficit in Patients With Acute PE
|
||
| Enrolling by invitation |
NCT04047784 -
Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients
|
N/A |